AEE
58
7
MUR
48
3
DNB
84
16
MDLZ
36
4
PSX
42
2
REGN
42
3
EXPE
96
5
GRMN
73
2
CME
59
4
SYY
49
2
ABT
62
5
PWR
74
5
WM
82
3
MPC
44
3
CHD
48
3
GWW
78
2
PGR
64
2
LRCX
52
2
FCX
63
-4
PHM
63
4
AEE
58
7
MUR
48
3
DNB
84
16
MDLZ
36
4
PSX
42
2
REGN
42
3
EXPE
96
5
GRMN
73
2
CME
59
4
SYY
49
2
ABT
62
5
PWR
74
5
WM
82
3
MPC
44
3
CHD
48
3
GWW
78
2
PGR
64
2
LRCX
52
2
FCX
63
-4
PHM
63
4
Financhill
Back

Mirum Pharmaceuticals 10K Form

Buy
75

MIRM
Mirum Pharmaceuticals

Last Price:
41.98
Seasonality Move:
32.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MIRM News And Ratings

See the #1 stock for the next 7 days that we like better than MIRM

MIRM Financial Statistics

Sales & Book Value

Annual Sales: $186.37M
Cash Flow: $-14.58M
Price / Cash Flow: 0
Annual Sales: $4.81
Price / Book: 8.75

Profitability

EPS (TTM): -2.33950
Net Income (TTM): $-109.16M
Gross Margin: $139.34M
Return on Equity: -51.5%
Return on Assets: -17.88%

Mirum Pharmaceuticals Earnings Forecast

Key Mirum Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 4 years for MIRM is 74.76%.
  • The Selling, General & Administrative Expenses for MIRM have been equal to 78.27% of Gross Profit Margin.
  • The Research & Development expenses have been 55.06% of Revenue.
  • The Interest Expense is -9.24% of Operating Income.
  • The Net Earning history of MIRM is -87.68% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 3 years.

Mirum Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MIRM
CUSIP: 604749
Website: mirumpharma.com

Debt

Debt-to-Equity Ratio: 1.34
Current Ratio: 3.28
Quick Ratio: 3.02

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MIRM Technical Analysis vs Fundamental Analysis

Buy
75
Mirum Pharmaceuticals (MIRM) is a Buy

Is Mirum Pharmaceuticals a Buy or a Sell?